Official publication of Rawalpindi Medical University
Enteric Fever as an Antecedent to Development of Miller-Fisher Syndrome and Possible Role of COVID-19 Vaccination

Supplementary Files

PDF

How to Cite

1.
Saleem TB, Ibrahim M, Fazal F, Rehman MEU, Ijaz AA, Nasim H. Enteric Fever as an Antecedent to Development of Miller-Fisher Syndrome and Possible Role of COVID-19 Vaccination. JRMC [Internet]. 2023 Dec. 30 [cited 2024 May 10];27(4). Available from: https://www.journalrmc.com/index.php/JRMC/article/view/2289

Abstract

Summary: Guillain-Barre Syndrome is an immune-mediated demyelinating disorder. Miller-Fisher Syndrome is an uncommon subtype of GBS. It is characterized by findings of ophthalmoplegia, ataxia, and areflexia. Here we present the case of Miller-Fisher Syndrome following an episode of typhoidal diarrhea. The presentation was of rapidly progressing weakness beginning in the lower extremity with diplopia. Examination revealed diminished reflexes. CSF testing revealed albuminocytologic dissociation which was later supported by neurophysiological testing. The patient was treated with intravenous immunoglobulins (IVIG).

We conclude that Miller-Fisher syndrome should be considered in the diagnostic workup of patients presenting with new sensorimotor deficits following diarrheal illnesses and/or COVID-19 mRNA vaccination. Early recognition is essential given the propensity of GBS to cause life-threatening respiratory failure and prompt IVIG administration is associated with a better prognosis.

Keywords: Enteric Fever, Miller-Fisher Syndrome, COVID-19, Vaccination

https://doi.org/10.37939/jrmc.v27i4.2289

References

Agha RA, Franchi T, Sohrabi C, Mathew G, for the SCARE Group: The SCARE. 20202020; 84:226-230. DOI:10.1016/j.ijsu.2020.10.034.

Snyder LA, Rismondo V, Miller NR: The Fisher variant of Guillain-Barré syndrome (Fisher syndrome). Journal of Neuro-Ophthalmology. 20091;29:312-24.DOI: 10.1097/WNO.0b013e3181c2514b

Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. Journal of Neurology, Neurosurgery & Psychiatry. 19931; 56:204-6.DOI: 10.1136/jnnp.56.2.204

Cabrero FR, Morrison EH: Miller Fisher Syndrome. InStatPearls. 2021;28.

Bukhari S, Taboada J: A case of Miller Fisher syndrome and literature review. Cureus. 2017;22:9.DOI: 10.7759/cureus.1048

Yepishin IV, Allison RZ, Kaminskas DA, Zagorski NM, Liow KK. Miller Fisher syndrome: a case report highlighting the heterogeneity of clinical features and focused differential diagnosis. Hawai'i Journal of Medicine & Public Health. 2016, 75:196.

Koga M, Kishi M, Fukusako T, Ikuta N, Kato M, Kanda T: Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics. Journal of Neurology. 2019, 266:1655-62.DOI:10.1007/s00415-019-09308-x.

Chida K, Nomura H, Konno H, Takase S, Itoyama Y. Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. Journal of the neurological sciences. 1999; 1:139-43.DOI: 10.1016/s0022-510x(99)00095-7.

Desai SS, Allen E, Deodhar A: Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations. Rheumatology. 20021, 41:216-22. 10.1093/rheumatology/41.2.216

Shoamanesh A, Chapman K, Traboulsee A: Postvaccination miller fisher syndrome. Archives of neurology. 20111, 68:1327-9.DOI: 10.1001/archneurol.2011.236

Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher Syndrome Following Vaccination against SARS-CoV-2. Internal Medicine. 20221;61:1067-9. DOI:10.2169/internalmedicine.8851-21.

Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z: Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature. Medicine. 202220;101:29333. DOI:10.1097/MD.0000000000029333

Michaelson NM, Lam T, Malhotra A, Schiff ND, MacGowan DJ. Miller Fisher syndrome presenting after a second dose of Pfizer-BioNTech vaccination in a patient with resolved COVID- 19: a case report. Journal of Clinical Neuromuscular Disease. 20211;23:113-5.DOI 10.1097/CND.0000000000000376.

Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H: Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology. 2021, 21:1-6. DOI:10.1186/s12883-021-02489-x.

Manganotti P, Pesavento V, Buoite Stella A, et al.: Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. Journal of NeuroVirology. 2020;26:605-6. DOI:10.1007/s13365-020-00858-9

Ángel-Páez JA, Hurtado-Bugna S, Aragón-Mendoza RL, Altman-Restrepo M, Díaz-Yamal IJ, Centanaro-Meza GA. Miller Fisher syndrome treated with plasmapheresis during pregnancy: Case report and review of the literature. RevistaColombiana de Obstetricia y Ginecología. 2021; 72:210-8.DOI:10.18597/rcog.3611.

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2023 Tayyaba Binte Saleem, Muhammad Ibrahim, Faizan Fazal, Mohammad Ebad Ur Rehman, Ali Ahmad Ijaz, Humera Nasim